Annexon (ANNX) Operating Leases (2021 - 2026)
Annexon's (ANNX) quarterly Operating Leases came in at $22.4 million in Q1 2026, down 12.74% year-on-year from $25.7 million in Q1 2025, and down 3.76% quarter-over-quarter from $23.3 million in Q4 2025.
Annexon (ANNX) Operating Leases (2021 - 2026) Analysis & Trends
Annexon's Operating Leases history runs 6 years deep, the most recent figure standing at $22.4 million for Q1 2026.
- On a quarterly basis, Operating Leases fell 12.74% year-over-year to $22.4 million in Q1 2026; TTM through Mar 2026 was $22.4 million, a 12.74% decrease from a year earlier, with the FY2025 full-year figure at $23.3 million, down 11.95% from the prior year.
- Operating Leases declined to $22.4 million in Q1 2026 per ANNX's latest filing, from $23.3 million in the prior quarter.
- Across five years, Operating Leases topped out at $32.9 million in Q1 2022 and bottomed at $22.4 million in Q1 2026.
- The 5-year median for Operating Leases is $28.5 million (2024), against an average of $28.2 million.
- Across the five-year window, Operating Leases grew 23.85% in 2022 and retreated 12.74% in 2026, its largest moves.
- Year by year, Operating Leases stood at $31.5 million in 2022, then declined by 7.46% to $29.2 million in 2023, then declined by 9.37% to $26.5 million in 2024, then retreated by 11.95% to $23.3 million in 2025, then fell by 3.76% to $22.4 million in 2026.
- Per Business Quant, the three latest ANNX Operating Leases figures stand at $22.4 million (Q1 2026), $23.3 million (Q4 2025), and $24.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Annexon | 1.03 Bn | 804.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.42 Mn |
| Dec 31, 2025 | 23.29 Mn |
| Sep 30, 2025 | 24.12 Mn |
| Jun 30, 2025 | 24.91 Mn |
| Mar 31, 2025 | 25.69 Mn |
| Dec 31, 2024 | 26.45 Mn |
| Sep 30, 2024 | 27.17 Mn |
| Jun 30, 2024 | 27.86 Mn |
| Mar 31, 2024 | 28.53 Mn |
| Dec 31, 2023 | 29.19 Mn |
| Sep 30, 2023 | 29.81 Mn |
| Jun 30, 2023 | 30.40 Mn |
| Mar 31, 2023 | 30.98 Mn |
| Dec 31, 2022 | 31.54 Mn |
| Sep 30, 2022 | 31.90 Mn |
| Jun 30, 2022 | 32.41 Mn |
| Mar 31, 2022 | 32.90 Mn |
| Dec 31, 2021 | 33.39 Mn |
| Sep 30, 2021 | 33.76 Mn |
| Jun 30, 2021 | 26.17 Mn |